Plasma-Derived, Pooled Human
Ryplazim is a human plasminogen replacement therapy used to treat patients with congenital plasminogen deficiency (type I hypoplasminogenemia), a rare genetic disorder. It works by replenishing plasminogen levels in the blood, which is converted to plasmin to help break down fibrin and other accumulated proteins in affected tissues.
Ryplazim is a plasminogen replacement therapy for treating congenital plasminogen deficiency, a rare genetic disorder.
Key facts at a glance
- RxNorm
- 2557206
- Generic
- Ryplazim
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Treatment of congenital plasminogen deficiency (type I hypoplasminogenemia), a rare genetic disorder characterized by inadequate plasminogen levels that can lead to fibrin-containing lesions affecting various tissues including the eyes, gums, respiratory tract, and other areas.
Ryplazim provides exogenous human plasminogen, which is converted to plasmin by the body's own activators. Plasmin is an enzyme that degrades fibrin clots and other proteins, helping to reduce lesion formation and improve symptoms in affected patients.
This is a specialty medication typically administered by healthcare professionals in appropriate clinical settings. Patients should be monitored for potential hypersensitivity reactions, bleeding, and thrombotic events. Treatment response varies among individuals, and regular assessment of clinical symptoms is important. Safety and effectiveness in children has been established. Patients should discuss complete medical history including bleeding disorders, recent surgeries, and current medications with their healthcare provider before starting treatment.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 9, 2026. · Read our editorial policy